Chargement en cours...
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
Patients with type 2 diabetes mellitus are at a higher risk of developing heart failure compared with the healthy population. In recent landmark clinical trials, sodium-glucose co-transporter 2 (SGLT2) inhibitor therapies improve blood glucose control and also reduce cardiovascular events and heart...
Enregistré dans:
| Publié dans: | Heart |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8223636/ https://ncbi.nlm.nih.gov/pubmed/33637556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2020-318060 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|